Compare FDC LTD. with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AUROBINDO PHARMA FDC LTD./
AUROBINDO PHARMA
 
P/E (TTM) x 17.4 14.5 120.1% View Chart
P/BV x 2.4 3.2 74.8% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 FDC LTD.   AUROBINDO PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-18
AUROBINDO PHARMA
Mar-18
FDC LTD./
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs319809 39.4%   
Low Rs164504 32.5%   
Sales per share (Unadj.) Rs61.6281.1 21.9%  
Earnings per share (Unadj.) Rs9.941.4 24.1%  
Cash flow per share (Unadj.) Rs12.050.9 23.5%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs73.2199.4 36.7%  
Shares outstanding (eoy) m174.40585.88 29.8%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.92.3 167.7%   
Avg P/E ratio x24.315.9 152.9%  
P/CF ratio (eoy) x20.212.9 156.4%  
Price / Book Value ratio x3.33.3 100.2%  
Dividend payout %06.0 0.0%   
Avg Mkt Cap Rs m42,118384,630 11.0%   
No. of employees `0005.517.3 31.9%   
Total wages/salary Rs m2,16721,308 10.2%   
Avg. sales/employee Rs Th1,943.79,500.7 20.5%   
Avg. wages/employee Rs Th391.71,229.4 31.9%   
Avg. net profit/employee Rs Th313.71,397.9 22.4%   
INCOME DATA
Net Sales Rs m10,751164,666 6.5%  
Other income Rs m5101,020 50.0%   
Total revenues Rs m11,260165,686 6.8%   
Gross profit Rs m2,26737,718 6.0%  
Depreciation Rs m3515,580 6.3%   
Interest Rs m14777 1.8%   
Profit before tax Rs m2,41132,380 7.4%   
Minority Interest Rs m-531 -15.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6718,183 8.2%   
Profit after tax Rs m1,73524,229 7.2%  
Gross profit margin %21.122.9 92.1%  
Effective tax rate %27.825.3 110.2%   
Net profit margin %16.114.7 109.7%  
BALANCE SHEET DATA
Current assets Rs m7,213121,878 5.9%   
Current liabilities Rs m2,10486,806 2.4%   
Net working cap to sales %47.521.3 223.1%  
Current ratio x3.41.4 244.2%  
Inventory Days Days54130 42.0%  
Debtors Days Days2868 40.6%  
Net fixed assets Rs m6,86581,037 8.5%   
Share capital Rs m175586 29.9%   
"Free" reserves Rs m12,586116,218 10.8%   
Net worth Rs m12,761116,804 10.9%   
Long term debt Rs m64,512 0.1%   
Total assets Rs m15,041211,052 7.1%  
Interest coverage x173.242.7 406.0%   
Debt to equity ratio x00 1.2%  
Sales to assets ratio x0.70.8 91.6%   
Return on assets %11.611.8 98.1%  
Return on equity %13.620.7 65.5%  
Return on capital %19.027.4 69.3%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88980,727 2.3%   
Fx outflow Rs m034,700 0.0%   
Net fx Rs m1,88946,027 4.1%   
CASH FLOW
From Operations Rs m1,49819,548 7.7%  
From Investments Rs m201-19,570 -1.0%  
From Financial Activity Rs m-1,6948,642 -19.6%  
Net Cashflow Rs m108,922 0.1%  

Share Holding

Indian Promoters % 68.9 54.1 127.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 8.0 59.1%  
FIIs % 7.5 27.7 27.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.2 186.3%  
Shareholders   23,730 69,601 34.1%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 13, 2019 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS